???global.info.a_carregar???
Identificação

Identificação pessoal

Nome completo
Qi Shi

Nomes de citação

  • Shi, Qi

Identificadores de autor

Ciência ID
CE1E-38EF-C924
ORCID iD
0000-0001-6530-0264

Endereços de correio eletrónico

  • sq880702@gmail.com (Pessoal)

Telefones

Telemóvel
  • (351) 911917942 (Pessoal)

Moradas

  • Rua Dom Nuno Alvares Botelho, 68 3Dto, 2870-827, Montijo, Setubal, Portugal (Pessoal)

Websites

Domínios de atuação

  • Ciências Médicas e da Saúde - Medicina Clínica
  • Ciências Exatas - Ciências da Computação e da Informação

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Chinês (Idioma materno)
Inglês Utilizador independente (B1) Utilizador proficiente (C1) Utilizador independente (B2) Utilizador independente (B1) Utilizador independente (B2)
Formação
Grau Classificação
2021/09/01 - 2024/02/02
Concluído
 Data Science and Advanced Analytics (Mestrado)
Universidade NOVA de Lisboa NOVA Information Management School, Portugal
"From Symptoms to Services: An LLM Chatbot for Effective Departmental Referral" (TESE/DISSERTAÇÃO)
2015/09/01 - 2019/04/01
Concluído
 Medical informatics (Mestrado)
Universidade do Porto Faculdade de Medicina, Portugal
"Monitoring the effectiveness of clinical guidelines: is the recommendation still valid?" (TESE/DISSERTAÇÃO)
2010/09/01 - 2017/06/01
Concluído
 Clinic medicine (Doktor (PhD))
The First Affiliated Hospital of Xi'an Jiaotong University, China
2005/09/01 - 2010/07/01
Concluído
 Clinical medicine (Bachelor)
Xi'an Jiaotong University, China
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento 		Empregador
2022/07/01 - Atual Investigador Contratado (Investigação) Universidade NOVA de Lisboa NOVA School of Business and Economics, Portugal
Universidade NOVA de Lisboa NOVA School of Business and Economics, Portugal
2018/06/01 - 2019/07/01 Investigador Contratado (Investigação) Emory University Winship Cancer Institute, Estados Unidos
2010/09/01 - 2017/06/01 Investigador (Investigação) The First Affiliated Hospital of Xi'an Jiaotong University, China
Produções

Publicações

Artigo em revista
  1. Jing Jia; Hai-Bao Zhang; Qi Shi; Chao Yang; Jian-Bin Ma; Bin Jin; Xinyang Wang; Dalin He; Peng Guo. "KLF5 downregulation desensitizes castration-resistant prostate cancer cells to docetaxel by increasing BECN1 expression and inducing cell autophagy: Erratum". Theranostics (2023): http://dx.doi.org/10.7150/thno.85499.
    10.7150/thno.85499
  2. Qi Shi. "Corrigendum to 'miR-145 inhibits invasion of bladder cancer cells by targeting PAK1'.". Urologic oncology (2022): https://doi.org/10.1016/j.urolonc.2022.05.009.
    10.1016/j.urolonc.2022.05.009
  3. Qi Shi. "Correction: Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer.". Oncotarget (2022): https://europepmc.org/articles/PMC8901075.
    10.18632/oncotarget.28206
  4. Qi Shi. "KLF5 inhibits STAT3 activity and tumor metastasis in prostate cancer by suppressing IGF1 transcription cooperatively with HDAC1.". Cell death & disease (2020): https://europepmc.org/articles/PMC7297795.
    10.1038/s41419-020-2671-1
  5. Qi Shi. "KLF5 downregulation desensitizes castration-resistant prostate cancer cells to docetaxel by increasing BECN1 expression and inducing cell autophagy.". Theranostics (2019): https://europepmc.org/articles/PMC6735397.
    10.7150/thno.33282
  6. Qi Shi. "Salen-Mn compounds induces cell apoptosis in human prostate cancer cells through promoting AMPK activity and cell autophagy.". Oncotarget (2017): https://europepmc.org/articles/PMC5689684.
    10.18632/oncotarget.21138
  7. Qi Shi. "KLF5 promotes apoptosis induced by phorbol ester as an effector of the autocrine factor TNFa in LNCaP prostate cancer cells.". Oncology letters (2017): https://europepmc.org/articles/PMC5529878.
    10.3892/ol.2017.6293
  8. Qi Shi. "Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer.". Oncotarget (2017): https://europepmc.org/articles/PMC5352391.
    10.18632/oncotarget.14131
  9. Qi Shi. "Long noncoding RNA DANCR promotes invasion of prostate cancer through epigenetically silencing expression of TIMP2/3.". Oncotarget (2016): https://europepmc.org/articles/PMC5122356.
    10.18632/oncotarget.9350
  10. Qi Shi. "Beyond proliferation: KLF5 promotes angiogenesis of bladder cancer through directly regulating VEGFA transcription.". Oncotarget (2015): https://europepmc.org/articles/PMC4791267.
    10.18632/oncotarget.6101
  11. Qi Shi. "FGF2-mediated reciprocal tumor cell-endothelial cell interplay contributes to the growth of chemoresistant cells: a potential mechanism for superficial bladder cancer recurrence.". Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine (2015): https://doi.org/10.1007/s13277-015-4214-4.
    10.1007/s13277-015-4214-4
  12. Qi Shi. "Krüppel-like factor 5 promotes apoptosis triggered by tumor necrosis factor a in LNCaP prostate cancer cells via up-regulation of mitogen-activated protein kinase kinase 7.". Urologic oncology (2015): https://doi.org/10.1016/j.urolonc.2015.09.004.
    10.1016/j.urolonc.2015.09.004
  13. Qi Shi. "G9a Inhibition Induces Autophagic Cell Death via AMPK/mTOR Pathway in Bladder Transitional Cell Carcinoma.". PloS one (2015): https://europepmc.org/articles/PMC4580411.
    10.1371/journal.pone.0138390
  14. Qi Shi. "Testosterone regulates keratin 33B expression in rat penis growth through androgen receptor signaling.". Asian journal of andrology (2014): https://europepmc.org/articles/PMC4236322.
    10.4103/1008-682x.129935
  15. Qi Shi. "Curcumin promotes KLF5 proteasome degradation through downregulating YAP/TAZ in bladder cancer cells.". International journal of molecular sciences (2014): https://europepmc.org/articles/PMC4200832.
    10.3390/ijms150915173
  16. Qi Shi. "miR-145 inhibits invasion of bladder cancer cells by targeting PAK1.". Urologic oncology (2014): https://doi.org/10.1016/j.urolonc.2014.01.003.
    10.1016/j.urolonc.2014.01.003
  17. Qi Shi. "[Acyldepsipeptide 1 induces apoptosis in renal cancer cells by down-regulation of Gli and Bcl-2 via SHH pathway].". Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology (2014):
  18. Zhang T; Qu S; Shi Q; He D; Jin X. "Evodiamine induces apoptosis and enhances TRAIL-induced apoptosis in human bladder cancer cells through mTOR/S6K1-mediated downregulation of Mcl-1.". International journal of molecular sciences (2014): https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24566141/?tool=EBI.
    10.3390/ijms15023154
  19. Chen Y; Zhang L; Lu X; Wu K; Zeng J; Yang Gao; Shi Q; et al. "Sinomenine reverses multidrug resistance in bladder cancer cells via P-glycoprotein-dependent and independent manners.". Die Pharmazie (2014):
  20. Qi Shi. "Acyldepsipeptides inhibit the growth of renal cancer cells through G1 phase cell cycle arrest.". Biochemical and biophysical research communications (2013): https://doi.org/10.1016/j.bbrc.2013.07.119.
    10.1016/j.bbrc.2013.07.119